The Asia Pacific Leadless Pacemakers Market would witness market growth of 16.7% CAGR during the forecast period (2023-2030).
The ability to avoid a number of problems associated with transvenous pacemakers and conventional leads, including pocket infections, hematoma, lead fractures, and lead dislodgment, is what has prompted the adoption of leadless pacemakers.
Moreover, leadless pacemakers have undergone significant technological advancements, driving the market's growth. These innovations include improvements in battery life, remote monitoring capabilities, and enhanced programming features. Patients can now benefit from longer-lasting devices, and healthcare providers can remotely monitor patients' cardiac data, leading to more proactive and personalized care.
In addition to these technological advancements, the market has been marked by increasing clinical evidence supporting the safety and efficacy of these devices. A growing body of research and clinical studies has demonstrated the comparable performance of leadless pacemakers to traditional devices, reassuring healthcare providers and patients about their effectiveness. This robust clinical foundation has accelerated the adoption of leadless pacemakers across healthcare settings.
According to the National Library of Medicine, the reported prevalence of AF in Asia Pacific countries varies from 0.49% to 5.4%. The majority of AF in those aged >70 or 80 years was 4.6%–8.2%. The prevalence of AF progressively increased more than twofold over the last 10 years and is significantly greater in men than in women for all years. AF prevalence in Thailand has been reported to be 1.9% for those aged ≥65 years and 2.2% in rural areas for those aged ≥60 years. AF prevalence in Korea is expected to be 5.8% in 2060 and 4.0% in Taiwan by 2050.
The same source also stated that after industrialization, the availability of processed foods and Westernization of dietary trends have resulted in an estimated 40.9% overweight/obese prevalence among adults in the Asia–Pacific region, with an estimated economic impact of up to 12% of total health care spending on obesity or related diseases. The rising prevalence of obesity in Asia has led to an increased incidence of heart-related conditions, including bradycardia and other arrhythmias. Obesity is a known risk factor for heart disease, as it can lead to structural changes in the heart and disrupt the electrical conduction system. Consequently, more individuals with obesity are at risk of requiring cardiac pacing, which has contributed to the demand for leadless pacemakers in this region.
The China market dominated the Asia Pacific Leadless Pacemakers Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $43,332.7 Thousands by 2030. The Japan market is registering a CAGR of 16% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 17.4% during (2023 - 2030).
Based on Type, the market is segmented into Micra Transcatheter Pacing System, and Others. Based on End-use, the market is segmented into Hospitals, and Outpatient Facilities. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Leadless Pacemakers Market is Predict to reach $827.7 Million by 2030, at a CAGR of 15.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd, Integer Holdings Corporation, MicroPort Scientific Corporation, Osypka AG, Terumo Corporation, and EBR Systems, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Micra Transcatheter Pacing System
- Others
By End-use
- Hospitals
- Outpatient Facilities
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Integer Holdings Corporation
- MicroPort Scientific Corporation
- Osypka AG
- Terumo Corporation
- EBR Systems, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Leadless Pacemakers Market, by Type
1.4.2 Asia Pacific Leadless Pacemakers Market, by End-use
1.4.3 Asia Pacific Leadless Pacemakers Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials & Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Nov – 2023, Sep) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Asia Pacific Leadless Pacemakers Market, By Type
5.1 Asia Pacific Micra Transcatheter Pacing System Market, By Country
5.2 Asia Pacific Others Market, By Country
Chapter 6. Asia Pacific Leadless Pacemakers Market, By End-use
6.1 Asia Pacific Hospitals Market, By Country
6.2 Asia Pacific Outpatient Facilities Market, By Country
Chapter 7. Asia Pacific Leadless Pacemakers Market, By Country
7.1 China Leadless Pacemakers Market
7.1.1 China Leadless Pacemakers Market, By Type
7.1.2 China Leadless Pacemakers Market, By End-use
7.2 Japan Leadless Pacemakers Market
7.2.1 Japan Leadless Pacemakers Market, By Type
7.2.2 Japan Leadless Pacemakers Market, By End-use
7.3 India Leadless Pacemakers Market
7.3.1 India Leadless Pacemakers Market, By Type
7.3.2 India Leadless Pacemakers Market, By End-use
7.4 South Korea Leadless Pacemakers Market
7.4.1 South Korea Leadless Pacemakers Market, By Type
7.4.2 South Korea Leadless Pacemakers Market, By End-use
7.5 Singapore Leadless Pacemakers Market
7.5.1 Singapore Leadless Pacemakers Market, By Type
7.5.2 Singapore Leadless Pacemakers Market, By End-use
7.6 Malaysia Leadless Pacemakers Market
7.6.1 Malaysia Leadless Pacemakers Market, By Type
7.6.2 Malaysia Leadless Pacemakers Market, By End-use
7.7 Rest of Asia Pacific Leadless Pacemakers Market
7.7.1 Rest of Asia Pacific Leadless Pacemakers Market, By Type
7.7.2 Rest of Asia Pacific Leadless Pacemakers Market, By End-use
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.5.4 Trials & Approval:
8.3.6 SWOT Analysis
8.4 Biotronik SE & Co. KG
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Trials & Approval:
8.4.3 SWOT Analysis
8.5 Lepu Medical Technology Co., Ltd
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Integer Holdings Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 MicroPort Scientific Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 OSYPKA AG
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Terumo Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. EBR Systems, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis
TABLE 1 Asia Pacific Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 2 Asia Pacific Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Leadless Pacemakers Market
TABLE 4 Product Launches And Product Expansions– Leadless Pacemakers Market
TABLE 5 Acquisition and Mergers– Leadless Pacemakers Market
TABLE 6 Trials & Approvals– Leadless Pacemakers Market
TABLE 7 Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 8 Asia Pacific Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 9 Asia Pacific Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
TABLE 10 Asia Pacific Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
TABLE 11 Asia Pacific Others Market, By Country, 2019 - 2022, USD Thousands
TABLE 12 Asia Pacific Others Market, By Country, 2023 - 2030, USD Thousands
TABLE 13 Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 14 Asia Pacific Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 15 Asia Pacific Hospitals Market, By Country, 2019 - 2022, USD Thousands
TABLE 16 Asia Pacific Hospitals Market, By Country, 2023 - 2030, USD Thousands
TABLE 17 Asia Pacific Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
TABLE 18 Asia Pacific Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
TABLE 19 Asia Pacific Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
TABLE 20 Asia Pacific Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
TABLE 21 China Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 22 China Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 23 China Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 24 China Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 25 China Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 26 China Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 27 Japan Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 28 Japan Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 29 Japan Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 30 Japan Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 31 Japan Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 32 Japan Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 33 India Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 34 India Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 35 India Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 36 India Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 37 India Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 38 India Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 39 South Korea Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 40 South Korea Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 41 South Korea Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 42 South Korea Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 43 South Korea Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 44 South Korea Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 45 Singapore Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 46 Singapore Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 47 Singapore Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 48 Singapore Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 49 Singapore Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 50 Singapore Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 51 Malaysia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 52 Malaysia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 53 Malaysia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 54 Malaysia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 55 Malaysia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 56 Malaysia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 57 Rest of Asia Pacific Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 58 Rest of Asia Pacific Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 59 Rest of Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 60 Rest of Asia Pacific Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 61 Rest of Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 62 Rest of Asia Pacific Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 63 Key Information – Medtronic PLC
TABLE 64 Key Information – Abbott Laboratories
TABLE 65 Key Information – Boston Scientific Corporation
TABLE 66 Key Information – Biotronik SE & Co. KG
TABLE 67 Key Information – Lepu Medical Technology Co., Ltd
TABLE 68 Key Information – Integer Holdings Corporation
TABLE 69 key Information – MicroPort Scientific Corporation
TABLE 70 Key Information – OSYPKA AG
TABLE 71 Key Information – Terumo Corporation
TABLE 72 Key Information – EBR Systems, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Leadless Pacemakers Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Leadless Pacemakers Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Nov – 2023, Sep) Leading Players
FIG 7 Porter’s Five Forces Analysis - Leadless Pacemakers Market
FIG 8 Asia Pacific Leadless Pacemakers Market share, By Type, 2022
FIG 9 Asia Pacific Leadless Pacemakers Market share, By Type, 2030
FIG 10 Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2030, USD Thousands
FIG 11 Asia Pacific Leadless Pacemakers Market share, By End-use, 2022
FIG 12 Asia Pacific Leadless Pacemakers Market share, By End-use, 2030
FIG 13 Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2030, USD Thousands
FIG 14 Asia Pacific Leadless Pacemakers Market share, By Country, 2022
FIG 15 Asia Pacific Leadless Pacemakers Market share, By Country, 2030
FIG 16 Asia Pacific Leadless Pacemakers Market, By Country, 2019 - 2030, USD Thousands
FIG 17 Recent strategies and developments: Medtronic PLC
FIG 18 SWOT Analysis: Medtronic PLC
FIG 19 Recent strategies and developments: Abbott Laboratories
FIG 20 SWOT Analysis: Abbott Laboratories
FIG 21 Recent strategies and developments: Boston Scientific Corporation
FIG 22 SWOT Analysis: Boston Scientific Corporation
FIG 23 SWOT Analysis: Biotronik SE & Co. KG
FIG 24 SWOT Analysis: Lepu Medical Technology Co., Ltd
FIG 25 SWOT Analysis: Integer Holdings Corporation
FIG 26 SWOT Analysis: MicroPort Scientific Corporation
FIG 27 SWOT Analysis: OSYPKA AG
FIG 28 Recent strategies and developments: Terumo Corporation
FIG 29 SWOT Analysis: Terumo Corporation
FIG 30 SWOT Analysis: EBR Systems, Inc.